Ikarian Capital, LLC Renovacor, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $2.18 $619 - $11,257	-5,164 Reduced 1.76%	288,119 $725,000
Q2 2022 Aug 12, 2022	SELL	$1.56 - $4.29 $78,000 - $214,500	-50,000 Reduced 14.57%	293,283 $595,000
Q1 2022 May 13, 2022	BUY	$4.02 - $8.23 $1,531 - $3,135	381 Added 0.11%	343,283 $1.46 Million
Q4 2021 Feb 14, 2022	SELL	$6.99 - $9.39 $699,000 - $939,000	-100,000 Reduced 22.58%	342,902 $2.64 Million
Q3 2021 Nov 15, 2021	BUY	$7.73 - $10.65 $3.42 Million - $4.72 Million	442,902 New	442,902 $4.01 Million

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.